Detalhe da pesquisa
1.
Real-Time Fluorescent Sentinel Lymph Node Mapping with Indocyanine Green in Women with Previous Conization Undergoing Laparoscopic Surgery for Early Invasive Cervical Cancer: Comparison with Radiotracer ± Blue Dye.
J Minim Invasive Gynecol
; 25(3): 455-460, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29032256
2.
Near-infrared Fluorescence-guided Sentinel Node Mapping of the Ovary With Indocyanine Green in a Minimally Invasive Setting: A Feasible Study.
J Minim Invasive Gynecol
; 24(1): 165-170, 2017 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27670732
3.
Indocyanine Green versus Radiotracer with or without Blue Dye for Sentinel Lymph Node Mapping in Stage >IB1 Cervical Cancer (>2 cm).
J Minim Invasive Gynecol
; 24(6): 954-959, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28571944
4.
Quality of Care for Cervical and Endometrial Cancer Patients: The Impact of Different Techniques of Sentinel Lymph Node Mapping on Patient Satisfaction.
Ann Surg Oncol
; 23(9): 2975-81, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27116680
5.
From Conventional Radiotracer Tc-99(m) with Blue Dye to Indocyanine Green Fluorescence: A Comparison of Methods Towards Optimization of Sentinel Lymph Node Mapping in Early Stage Cervical Cancer for a Laparoscopic Approach.
Ann Surg Oncol
; 23(9): 2959-65, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27126631
6.
Sentinel Lymph Node Mapping With Near-Infrared Fluorescent Imaging Using Indocyanine Green: A New Tool for Laparoscopic Platform in Patients With Endometrial and Cervical Cancer.
J Minim Invasive Gynecol
; 23(2): 265-9, 2016 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26455525
7.
Dacomitinib (PF-00299804), a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor, demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro.
Tumour Biol
; 36(7): 5505-13, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25669172
8.
Neratinib shows efficacy in the treatment of HER2 amplified carcinosarcoma in vitro and in vivo.
Gynecol Oncol
; 139(1): 112-7, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26260909
9.
Optimizing Strategies for Sentinel Lymph Node Mapping in Early-Stage Cervical and Endometrial Cancer: Comparison of Real-Time Fluorescence With Indocyanine Green and Methylene Blue.
Int J Gynecol Cancer
; 25(8): 1513-8, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26397069
10.
The impact of different doses of indocyanine green on the sentinel lymph-node mapping in early stage endometrial cancer.
J Cancer Res Clin Oncol
; 144(11): 2187-2191, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30043278
11.
Correction to: The impact of different doses of indocyanine green on the sentinel lymph-node mapping in early stage endometrial cancer.
J Cancer Res Clin Oncol
; 144(11): 2193, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30196439
12.
Sentinel lymph node mapping in patients with stage I endometrial carcinoma: a focus on bilateral mapping identification by comparing radiotracer Tc99m with blue dye versus indocyanine green fluorescent dye.
J Cancer Res Clin Oncol
; 143(3): 475-480, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27812854